Naloxone HCL Spray (Naloxone Hydrochloride Nasal Spray) 1.26mg

Naloxone HCL Spray is a nasal spray used to reverse opioid overdose symptoms. It contains 1.26mg of Naloxone Hydrochloride per dose. This emergency medication is designed for quick administration in suspected opioid emergencies. Keep it accessible for rapid response.

Strength

1.26mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Pharma Production AS

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Naloxone HCL Spray is used to temporarily reverse the effects of opioid overdose, including respiratory depression. It works by blocking opioid receptors in the brain. This spray is intended for emergency use when opioid overdose is suspected. It helps restore normal breathing until medical help arrives.

Side Effects

When administered, Naloxone HCL Spray may quickly restore breathing in cases of opioid overdose. Users may experience a return to consciousness and improved alertness. Effects typically begin within 2 to 5 minutes after use. It does not treat the underlying cause of overdose but provides critical time for further medical intervention.

Precautions & Warnings

Store Naloxone HCL Spray at room temperature and protect it from light. Check the expiration date regularly and replace before it expires. Always follow the included instructions for proper use. Keep it out of reach of children and pets. Do not use if the spray is discolored or contains particles.

Avoid Interactions

Naloxone HCL Spray may interact with other opioid medications, potentially reversing their effects. It does not interact with non-opioid substances like alcohol or common medications. Always inform emergency responders about any medications taken. Repeated doses may be necessary if overdose symptoms return.

Frequently Asked Questions

Follow the instructions provided with the spray. Administer into one nostril while the person is lying on their back.

It may be used in children if opioid overdose is suspected, but medical advice should be sought immediately.

Call emergency services right away, even if the person wakes up. Monitor for recurring overdose symptoms.

In many regions, it is available without a prescription for emergency use. Check local regulations.

Effects typically begin within 2 to 5 minutes after administration.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.